Bristol Myers Squibb Co (BMY) Other Working Capital Changes (2009 - 2012)

Bristol Myers Squibb (BMY) has reported Other Working Capital Changes for 18 consecutive years, with -$786.0 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Other Working Capital Changes fell 254.05% year-over-year to -$786.0 million; the TTM figure through Jun 2026 stood at -$458.0 million (down 732.73% YoY), while the FY2025 annual figure was -$471.0 million, up 24.52% from the prior year.
• Other Working Capital Changes declined to -$786.0 million in Q2 2026 per BMY's latest filing, from $1.6 billion in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $3.6 billion in Q3 2012 and bottomed at -$91.0 million in Q1 2012.
• Historically, Other Working Capital Changes has averaged $302.7 million across 4 years, with a median of -$2.0 million in 2010.
• Annual changes were most pronounced in 2022 — Other Working Capital Changes jumped 185.27% — and 2024, when it tumbled 383.05%.
• Bristol Myers Squibb's Other Working Capital Changes stood at -$700.0 million in 2022, then surged by 59.57% to -$283.0 million in 2023, then plunged by 156.18% to -$725.0 million in 2024, then slumped by 47.31% to -$1.1 billion in 2025, then increased by 26.4% to -$786.0 million in 2026.
• Business Quant data shows BMY's Other Working Capital Changes at -$786.0 million in Q2 2026, $1.6 billion in Q1 2026, and -$1.1 billion in Q4 2025.